Author

Kathe Stauber

Preclinical and Clinical Efficacy of Olorinab, a Peripherally Restricted, Highly Selective Full Agonist of the Cannabinoid Type 2 Receptor for the Management of Visceral Pain in Inflammatory Bowel Disease

Bruce Yacyshyn, Stuart M. Brierley, Beatriz Lindstrom, John Adams, Stewart Turner, Brett A. English, Kathe Stauber, Peter D.R. Higgins

Item 1 - 1 / 1
1